Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

ATS Medical raises settlement funds: Heart valve manufacturer raises $20 million through the sale of 8.5 million shares of its common stock at $2.35 each, plus warrants to buy 2.5 million more shares at various prices, to venture capital firm Essex Woodlands Health Ventures. A portion of the proceeds will be used to settle a 2007 lawsuit filed by Carbomedics over a mechanical heart valve component supply agreement. The settlement, announced in conjunction with the financing on Dec. 22, will enable ATS to continue to make and sell its Open Pivot mechanical heart valve in exchange for a $3 million payment to Carbomedics on Dec. 29, 2008, and an additional $4.5 million on April 30, 2009

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel